1. Home
  2. LIDR vs FATE Comparison

LIDR vs FATE Comparison

Compare LIDR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • FATE
  • Stock Information
  • Founded
  • LIDR 2013
  • FATE 2007
  • Country
  • LIDR United States
  • FATE United States
  • Employees
  • LIDR N/A
  • FATE N/A
  • Industry
  • LIDR Auto Parts:O.E.M.
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LIDR Consumer Discretionary
  • FATE Health Care
  • Exchange
  • LIDR Nasdaq
  • FATE Nasdaq
  • Market Cap
  • LIDR 108.6M
  • FATE 125.7M
  • IPO Year
  • LIDR N/A
  • FATE 2013
  • Fundamental
  • Price
  • LIDR $2.82
  • FATE $1.04
  • Analyst Decision
  • LIDR
  • FATE Hold
  • Analyst Count
  • LIDR 0
  • FATE 6
  • Target Price
  • LIDR N/A
  • FATE $3.30
  • AVG Volume (30 Days)
  • LIDR 8.4M
  • FATE 1.5M
  • Earning Date
  • LIDR 07-31-2025
  • FATE 08-12-2025
  • Dividend Yield
  • LIDR N/A
  • FATE N/A
  • EPS Growth
  • LIDR N/A
  • FATE N/A
  • EPS
  • LIDR N/A
  • FATE N/A
  • Revenue
  • LIDR $236,000.00
  • FATE $8,470,000.00
  • Revenue This Year
  • LIDR $2,677.23
  • FATE N/A
  • Revenue Next Year
  • LIDR $409.09
  • FATE N/A
  • P/E Ratio
  • LIDR N/A
  • FATE N/A
  • Revenue Growth
  • LIDR N/A
  • FATE N/A
  • 52 Week Low
  • LIDR $0.49
  • FATE $0.66
  • 52 Week High
  • LIDR $6.44
  • FATE $4.20
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 53.26
  • FATE 44.22
  • Support Level
  • LIDR $2.37
  • FATE $1.07
  • Resistance Level
  • LIDR $3.49
  • FATE $1.18
  • Average True Range (ATR)
  • LIDR 0.32
  • FATE 0.09
  • MACD
  • LIDR -0.04
  • FATE 0.00
  • Stochastic Oscillator
  • LIDR 40.18
  • FATE 37.50

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: